Table 3 Prevalence of OLLMM in different clinical subgroups (based on percentage BF)
From: The prevalence of low muscle mass associated with obesity in the USA
Clinical subgroups | With OLLMM, n | Eligible participants, n | With OLLMM, weighted, n | Eligible participants, weighted, n | Prevalence OLLMM,a % (95% CI) |
|---|---|---|---|---|---|
T2DM, no | 527 | 3277 | 19,589,822 | 154,709,933 | 12.7 (10.5–14.8) |
T2DM, yes | 300 | 897 | 9,138,598 | 26,466,664 | 34.5 (29.5–39.6) |
Prediabetes, no | 577 | 3060 | 20,645,798 | 140,079,916 | 14.7 (12.1–17.4) |
Prediabetes, yes | 250 | 1114 | 8,082,622 | 41,096,682 | 19.7 (16.6–22.7) |
NAFLD with fibrosis, no | 366 | 2408 | 14,954,200 | 119,957,621 | 12.5 (10.3–14.6) |
NAFLD with fibrosis, yes | 39 | 109 | 1,109,842 | 4,361,071 | 25.4 (15.7–35.2) |
Bariatric surgery, no | 811 | 4122 | 28,170,588 | 178,616,433 | 15.8 (13.5–18.0) |
Bariatric surgery, yes | 16 | 52 | 557,833 | 2,560,164 | 21.8 (8.6–35.0) |
BMI, kg/m2 | |||||
 < 30 | 340 | 2510 | 9,961,709 | 108,595,331 | 9.2 (7.8–10.6) |
 30 to < 35 | 240 | 896 | 8,553,115 | 40,325,428 | 21.2 (16.9–25.5) |
 35 to < 40 | 133 | 430 | 6,227,994 | 19,277,764 | 32.3 (25.9–38.7) |
 ≥ 40 | 113 | 283 | 3,953,401 | 11,292,403 | 35.0 (26.1–43.9) |